Zivo Bioscience, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US98978N3098
USD
8.25
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Traws Pharma, Inc.
Frequency Therapeutics, Inc.
VBI Vaccines, Inc.
GeoVax Labs, Inc.
Surrozen, Inc.
Applied DNA Sciences, Inc.
Longeveron, Inc.
Microbot Medical, Inc.
Zivo Bioscience, Inc.
BiomX, Inc.
CalciMedica, Inc.

Why is Zivo Bioscience, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Zivo Bioscience, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Zivo Bioscience, Inc.
-54.17%
0.23
144.15%
S&P 500
13.68%
0.62
19.74%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
13.00%
EBIT Growth (5y)
-84.02%
EBIT to Interest (avg)
-6.44
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
-0.06
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.14%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-10.65
EV to EBIT
-2.66
EV to EBITDA
-2.66
EV to Capital Employed
-12.95
EV to Sales
35.54
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

22What is working for the Company
NET SALES(HY)

At USD 0.12 MM has Grown at 277.86%

OPERATING CASH FLOW(Y)

Highest at USD -3.09 MM

RAW MATERIAL COST(Y)

Fallen by -8.41% (YoY

OPERATING PROFIT(Q)

Highest at USD -1.02 MM

PRE-TAX PROFIT(Q)

Highest at USD -1.03 MM

NET PROFIT(Q)

Highest at USD -1.03 MM

EPS(Q)

Highest at USD -0.27

-4What is not working for the Company
INTEREST(HY)

At USD 0.02 MM has Grown at 32.58%

Here's what is working for Zivo Bioscience, Inc.

Net Sales
At USD 0.12 MM has Grown at 277.86%
Year on Year (YoY)
MOJO Watch
Sales trend is very positive

Net Sales (USD MM)

Operating Cash Flow
Highest at USD -3.09 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Operating Profit
Highest at USD -1.02 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (USD MM)

Pre-Tax Profit
Highest at USD -1.03 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Pre-Tax Profit
At USD -1.03 MM has Grown at 54.46%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -1.03 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

Net Profit
At USD -1.03 MM has Grown at 54.46%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -0.27
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -8.41% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Zivo Bioscience, Inc.

Interest
At USD 0.02 MM has Grown at 32.58%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)